Open-label extension treatment with TNFR:Fc [etanercept] for participating patients in TNFR:Fc clinical trial 016.0012.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Amgen
- 25 Aug 2009 Actual patient number (468) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2006 New trial record.